evidenced that the reduced expression of RGL4 was remarkably related to unfavorable prognostic results and immunocyte infiltrative activities in lung adenocarcinoma (LUAD) cases and highlighted the utilization of RGL4 as a new prediction marker for the prognostic results of LUAD (52). The gene discussed is RGL4; the disease is lung adenocarcinoma.